Sitagliptin and alogliptin go head-to-head in Japan
24 May 2011
Ian Haydock
Please Login to read the full article.
24 May 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mitsubishi Tanabe's Japan diabetes alliance reflects competitive market
- DSP aims to extend Japan repaglinide use through new filing
- Three month review delay in US sets Takeda's alogliptin further back in diabetes
- EC approval for BI/Lilly's one-dosage Trajenta for type 2 diabetes
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
